RAI is absorbed into thyroid tumor cells via NIS, releasing β rays that effectively destroy residual thyroid cancer cells within a range of 2.4 mm (23, 24), thereby playing an important role in the treatment of thyroid cancer. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.